Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Lodivikar vs Sevikar in Healthy Males
NCT02955498Phase 1Completed
- Sponsor
- Hanlim Pharm
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Lodivikar in hypertension (HTN) (2 arms), sponsored by Hanlim Pharm. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Started Apr 2014; status: completed.
02
Drugs
Lodivikar
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02955498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955498.